Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A17040 | 28035202 | Gastroenterol Hepatol (N Y) | Nonalcoholic Steatohepatitis and Endpoints in Clinical Trials. | 2016 | Details |
| A17041 | 28034722 | Brain Res | Specific regions of the brain are capable of fructose metabolism. | 2016 | Details |
| A17042 | 28033294 | Medicine (Baltimore) | The expression of thymosin β4 in chronic hepatitis B combined nonalcoholic fatty liver disease. | 2016 | Details |
| A17043 | 28032901 | Clin Pharmacol Ther | Structure of proof of concept studies that precede a nonalcoholic steatohepatitis development program. | 2016 | Details |
| A17044 | 28032449 | Diabetes Metab Res Rev | Occurrence over time and regression of nonalcoholic fatty liver disease in type 2 diabetes. | 2017 | Details |
| A17045 | 28030556 | PLoS One | Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17046 | 28030540 | PLoS One | Severe Atherosclerosis and Hypercholesterolemia in Mice Lacking Both the Melanocortin Type 4 Receptor and Low Density Lipoprotein Receptor. | 2016 | Details |
| A17047 | 28029021 | Endocrinol Metab (Seoul) | Bile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17048 | 28028821 | Aliment Pharmacol Ther | Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A17049 | 28028366 | World J Gastroenterol | Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat. | 2016 | Details |
| A17050 | 28028356 | World J Gastroenterol | Sirtuins and nonalcoholic fatty liver disease. | 2016 | Details |
| A17051 | 28027934 | Biochem Biophys Res Commun | Histone modifications in FASN modulated by sterol regulatory element-binding protein 1c and carbohydrate responsive-element binding protein under insulin stimulation are related to NAFLD. | 2016 | Details |
| A17052 | 28027788 | Atherosclerosis | Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage. | 2016 | Details |
| A17053 | 28027586 | Hepatology | Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis. | 2017 | Details |
| A17054 | 28025996 | Int J Mol Med | Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice. | 2016 | Details |
| A17055 | 28025059 | J Hepatol | MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis. | 2016 | Details |
| A17056 | 28019064 | Hepatol Res | Novel antidiabetic medications for non-alcoholic fatty liver disease with type 2 diabetes mellitus. | 2017 | Details |
| A17057 | 28018114 | World J Gastroenterol | Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis. | 2016 | Details |
| A17058 | 28017785 | Mol Cell Endocrinol | Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging. | 2016 | Details |
| A17059 | 28017631 | Diabetes Metab Syndr | Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysis. | 2016 | Details |
| A17060 | 28017576 | Prim Care Diabetes | Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients. | 2016 | Details |
| A17061 | 28013023 | Semin Cell Dev Biol | Metabolic roles of poly(ADP-ribose) polymerases. | 2016 | Details |
| A17062 | 28012599 | Med Hypotheses | Blood oxidative stress (BLOS) is a secondary host defense system responding normally to anaerobic wound infection and inadvertently to dietary ultra-exogenous sulfide formation (USF). | 2016 | Details |
| A17064 | 28012259 | Hepatology | Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy. | 2016 | Details |
| A17066 | 28012135 | Lipids | Eicosapentaenoic Acid-Enriched Phosphatidylcholine Attenuated Hepatic Steatosis Through Regulation of Cholesterol Metabolism in Rats with Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17067 | 28011892 | Gut | Adipose type I interferon signalling protects against metabolic dysfunction. | 2016 | Details |
| A17068 | 28011404 | Biochim Biophys Acta Mol Cell Biol Lipids | Regulation of SREBP-2 intracellular trafficking improves impaired autophagic flux and alleviates endoplasmic reticulum stress in NAFLD. | 2016 | Details |
| A17069 | 28011152 | Transl Res | Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicity. | 2016 | Details |
| A17070 | 28008992 | Sci Rep | Acylated and desacyl ghrelin are associated with hepatic lipogenesis, β-oxidation and autophagy: role in NAFLD amelioration after sleeve gastrectomy in obese rats. | 2016 | Details |
| A17072 | 28008583 | Exp Clin Endocrinol Diabetes | EndoBarrier Gastrointestinal Liner in Type 2 Diabetic Patients Improves Liver Fibrosis as Assessed by Liver Elastography. | 2016 | Details |
| A17073 | 28007783 | FASEB J | Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice. | 2016 | Details |
| A17074 | 28007354 | Sleep Med | Gut epithelial barrier markers in patients with obstructive sleep apnea. | 2016 | Details |
| A17075 | 28006772 | Cell Physiol Biochem | Involvement of Sphingosine 1-Phosphate in Palmitate-Induced Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A17076 | 28006764 | Cytogenet Genome Res | Telomere Dysfunction in Nonalcoholic Fatty Liver Disease and Cryptogenic Cirrhosis. | 2016 | Details |
| A17077 | 28003718 | J Clin Exp Hepatol | Histological Evaluation of Non-alcoholic Fatty Liver Disease and Its Correlation with Different Noninvasive Scoring Systems with Special Reference to Fibrosis: A Single Center Experience. | 2016 | Details |
| A17078 | 28003715 | J Clin Exp Hepatol | High-Fructose Intake Impairs the Hepatic Hypolipidemic Effects of a High-Fat Fish-Oil Diet in C57BL/6 Mice. | 2016 | Details |
| A17079 | 28002874 | J Gastroenterol Hepatol | High serum alanine aminotransferase is associated with the risk of colorectal adenoma in Korean men. | 2017 | Details |
| A17080 | 28002036 | Rom J Intern Med | Serum Levels of Oxidative Stress Markers in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Steatohepatitis. | 2016 | Details |
| A17081 | 28001263 | Rev Assoc Med Bras (1992) | Current management of non-alcoholic fatty liver disease. | 2016 | Details |
| A17082 | 28000843 | Int J Mol Med | Wheat-bran autolytic peptides containing a branched-chain amino acid attenuate non-alcoholic steatohepatitis via the suppression of oxidative stress and the upregulation of AMPK/ACC in high-fat diet-fed mice. | 2016 | Details |
| A17083 | 27999887 | Abdom Radiol (NY) | Imaging patterns and focal lesions in fatty liver: a pictorial review. | 2017 | Details |
| A17084 | 27999641 | Caspian J Intern Med | Assessment of transient elastography (FibroScan) for diagnosis of fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2016 | Details |
| A17085 | 27999564 | Front Endocrinol (Lausanne) | Distinct Hepatic Macrophage Populations in Lean and Obese Mice. | 2016 | Details |
| A17086 | 27999105 | Diabetes | Hepatic DPP4 DNA Methylation Associates With Fatty Liver. | 2016 | Details |
| A17087 | 27998724 | Am J Pathol | Global Deletion of Glutathione S-Transferase A4 Exacerbates Developmental Nonalcoholic Steatohepatitis. | 2016 | Details |
| A17088 | 27998425 | Zhonghua Yi Xue Za Zhi | [Prevalence of nonalcoholic fatty liver disease and its correlated risk factors in health population in Guangzhou]. | 2016 | Details |
| A17089 | 27997977 | Semin Liver Dis | Regulation of Hepatocellular Fatty Acid Uptake in Mouse Models of Fatty Liver Disease with and without Functional Leptin Signaling: Roles of NfKB and SREBP-1C and the Effects of Spexin. | 2016 | Details |
| A17090 | 27997970 | Semin Liver Dis | The Metabolic Role of the Microbiome: Implications for NAFLD and the Metabolic Syndrome. | 2016 | Details |
| A17091 | 27996362 | Toxicol Mech Methods | The effects of di 2-ethyl hexyl phthalate (DEHP) on cellular lipid accumulation in HepG2 cells and its potential mechanisms in the molecular level. | 2017 | Details |
| A17092 | 27996033 | Sci Rep | The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through Autophagy. | 2016 | Details |
| A17093 | 27995906 | Am J Gastroenterol | ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. | 2016 | Details |
| A17095 | 27995401 | Dig Dis Sci | Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey. | 2016 | Details |
| A17096 | 27995280 | Arch Toxicol | Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD). | 2016 | Details |
| A17097 | 27995261 | Singapore Med J | Interval increase in the prevalence of symptomatic cholelithiasis-associated non-alcoholic fatty liver disease over a ten-year period in an Asian population. | 2016 | Details |
| A17098 | 27993651 | Biochim Biophys Acta Mol Cell Biol Lipids | NAFLD is associated with methylation shifts with relevance for the expression of genes involved in lipoprotein particle composition. | 2016 | Details |
| A17099 | 27992443 | PLoS One | Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD. | 2016 | Details |
| A17100 | 27992361 | J Pediatr Endocrinol Metab | Risk factors that affect metabolic health status in obese children. | 2017 | Details |
| A17101 | 27991906 | Lab Invest | Hepatic stimulator substance inhibits calcium overflow through the mitochondria-associated membrane compartment during nonalcoholic steatohepatitis. | 2016 | Details |
| A17102 | 27991855 | Turk J Gastroenterol | Promotional effect of nonalcoholic fatty liver disease on Gallstone disease: A systematic review and meta-analysis. | 2016 | Details |
| A17103 | 27990792 | Minerva Endocrinol | Diabetes mellitus and non-alcoholic fatty liver disease: the thread of Ariadne. | 2016 | Details |
| A17104 | 27989689 | Clin Res Hepatol Gastroenterol | CD40 signaling and hepatic steatosis: Unanticipated links. | 2016 | Details |
| A17105 | 27989517 | Diabetes Metab Syndr | Significant disparities in risks of diabetes mellitus and metabolic syndrome among chronic hepatitis C virus patients in the U.S. | 2016 | Details |
| A17106 | 27988988 | Clin Transplant | Prediction of nonalcoholic fatty liver in prospective liver donors. | 2017 | Details |
| A17107 | 27988872 | Drugs | Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease. | 2017 | Details |
| A17108 | 27988847 | Eur J Nutr | Calcium and vitamin D3 combinations improve fatty liver disease through AMPK-independent mechanisms. | 2016 | Details |
| A17110 | 27986627 | Eur J Pharmacol | A novel and selective melanin-concentrating hormone receptor 1 antagonist ameliorates obesity and hepatic steatosis in diet-induced obese rodent models. | 2016 | Details |
| A17111 | 27986466 | Trends Endocrinol Metab | Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies. | 2016 | Details |
| A17113 | 27986169 | Semin Ultrasound CT MR | Hepatic Steatosis: Etiology, Patterns, and Quantification. | 2016 | Details |
| A17114 | 27984800 | Biomed Pharmacother | Saponins from the roots of Platycodon grandiflorum ameliorate high fat diet-induced non-alcoholic steatohepatitis. | 2016 | Details |
| A17115 | 27984419 | J Dev Behav Pediatr | Family Functioning Predicts Body Mass Index and Biochemical Levels of Youths with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A17116 | 27984176 | J Hepatol | PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis. | 2016 | Details |
| A17117 | 27982761 | Radiology | Liver Stiffness in Pediatric Patients with Fatty Liver Disease: Diagnostic Accuracy and Reproducibility of Shear-Wave Elastography. | 2016 | Details |
| A17118 | 27982256 | Acta Cir Bras | Effect of curcumin on visfatin and zinc-α2-glycoprotein in a rat model of non-alcoholic fatty liver disease. | 2016 | Details |
| A17119 | 27982131 | Sci Rep | CREB3L3 controls fatty acid oxidation and ketogenesis in synergy with PPARα. | 2016 | Details |
| A17120 | 27981809 | Mol Nutr Food Res | Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency. | 2017 | Details |
| A17121 | 27981615 | Hepatology | Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease. | 2017 | Details |
| A17122 | 27981274 | Med Ultrason | Noninvasive quantitative estimation of hepatic steatosis by ultrasound: a comparison of the hepato-renal index and ultrasound attenuation index. | 2016 | Details |
| A17123 | 27980597 | Nutr Metab (Lond) | Alpha-mangostin from mangosteen (Garcinia mangostana Linn.) pericarp extract reduces high fat-diet induced hepatic steatosis in rats by regulating mitochondria function and apoptosis. | 2016 | Details |
| A17124 | 27980239 | Endocr J | Amelioration of fatty liver index in patients with type 2 diabetes on ipragliflozin: an association with glucose-lowering effects. | 2016 | Details |
| A17125 | 27979751 | J Hepatol | PARP1-mediated PPARα poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease. | 2016 | Details |
| A17126 | 27978932 | Zhonghua Gan Zang Bing Za Zhi | [Preventive and therapeutic effects of compound ginkgo extract in rats with nonalcoholic steatohepatitis induced by high-fat, high-fructose diet]. | 2016 | Details |
| A17127 | 27977757 | PLoS One | Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial. | 2016 | Details |
| A17128 | 27976696 | Sci Rep | Phospholipase D1 deficiency in mice causes nonalcoholic fatty liver disease via an autophagy defect. | 2016 | Details |
| A17129 | 27976635 | Saudi J Gastroenterol | Outcome of phlebotomy for treating nonalcoholic fatty liver disease: A systematic review and meta-analysis. | 2016 | Details |
| A17130 | 27974597 | Nutr Rev | What is the appropriate upper limit for added sugars consumption? | 2017 | Details |
| A17131 | 27974211 | Cell Rep | Dual Shp2 and Pten Deficiencies Promote Non-alcoholic Steatohepatitis and Genesis of Liver Tumor-Initiating Cells. | 2016 | Details |
| A17132 | 27973757 | Clin Exp Pharmacol Physiol | Alleviative effect of ciliary neurotrophic factor analogue on high fat-induced hepatic steatosis is partially independent of the central regulation. | 2017 | Details |
| A17133 | 27973461 | Minerva Endocrinol | Bone metabolism in non-alcoholic fatty liver disease: vitamin D status and bone mineral density. | 2016 | Details |
| A17134 | 27973460 | Minerva Endocrinol | Adrenal disorders and non-alcoholic fatty liver disease. | 2016 | Details |
| A17135 | 27973438 | Int J Mol Sci | Pathophysiology of Non Alcoholic Fatty Liver Disease. | 2016 | Details |
| A17136 | 27973423 | Nutrients | Regressive Effect of Myricetin on Hepatic Steatosis in Mice Fed a High-Fat Diet. | 2016 | Details |
| A17137 | 27967209 | Antioxid Redox Signal | Cluster of Differentiation 36 Deficiency Aggravates Macrophage Infiltration and Hepatic Inflammation by Upregulating Monocyte Chemotactic Protein-1 Expression of Hepatocytes Through Histone Deacetylase 2-Dependent Pathway. | 2017 | Details |
| A17139 | 27966386 | Hematology | More on the thrombocytopenia of the non-alcoholic fatty liver disease. | 2016 | Details |
| A17140 | 27966066 | Obes Surg | Effects of Bariatric Surgery on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A17141 | 27965104 | Genomics Proteomics Bioinformatics | Identification of Risk Pathways and Functional Modules for Coronary Artery Disease Based on Genome-wide SNP Data. | 2016 | Details |
| A17142 | 27960079 | Cancer Cell | Liver Cancer Checks in When Bile Acid Clocks Out. | 2016 | Details |
| A17143 | 27959936 | PLoS One | A Low Dose of Dietary Quercetin Fails to Protect against the Development of an Obese Phenotype in Mice. | 2016 | Details |
| A17144 | 27959408 | Mol Med Rep | Involvement of xanthine oxidase and paraoxonase 1 in the process of oxidative stress in nonalcoholic fatty liver disease. | 2016 | Details |
| A17145 | 27957696 | Sleep Breath | The association between continuous positive airway pressure therapy and liver disease development in obstructive sleep apnea/hypopnea syndrome patients: a nationwide population-based cohort study in Taiwan. | 2016 | Details |
| A17146 | 27957651 | Metab Brain Dis | Carnosic acid protects non-alcoholic fatty liver-induced dopaminergic neuron injury in rats. | 2016 | Details |